Grantham, Mayo, Van Otterloo & Co (GMO)’s PotlatchDeltic PCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-178,189
Closed -$7.09M 703
2025
Q4
$7.09M Buy
178,189
+3,389
+2% +$137K 0.02% 269
2025
Q3
$7.12M Buy
174,800
+43,200
+33% +$1.79M 0.02% 260
2025
Q2
$5.05M Buy
+131,600
New +$5.17M 0.02% 294
2025
Q1
Sell
-348,323
Closed -$13.7M 662
2024
Q4
$13.7M Buy
348,323
+79,500
+30% +$3.37M 0.04% 229
2024
Q3
$12.1M Sell
268,823
-308,504
-53% -$13.1M 0.04% 252
2024
Q2
$22.7M Sell
577,327
-303,567
-34% -$12.9M 0.08% 170
2024
Q1
$41.4M Buy
880,894
+149,195
+20% +$6.87M 0.15% 95
2023
Q4
$35.9M Sell
731,699
-27,727
-4% -$1.27M 0.16% 113
2023
Q3
$34.5M Buy
759,426
+133,066
+21% +$6.57M 0.16% 115
2023
Q2
$33.1M Sell
626,360
-90,737
-13% -$4.36M 0.15% 120
2023
Q1
$35.5M Sell
717,097
-88,776
-11% -$4.17M 0.18% 110
2022
Q4
$35.5M Buy
805,873
+163,976
+26% +$7.42M 0.19% 112
2022
Q3
$26.3M Buy
641,897
+164,546
+34% +$7.56M 0.15% 137
2022
Q2
$21.1M Buy
477,351
+125,165
+36% +$6.46M 0.11% 189
2022
Q1
$18.6M Buy
352,186
+144,075
+69% +$7.86M 0.09% 186
2021
Q4
$12.5M Sell
208,111
-5,671
-3% -$318K 0.06% 219
2021
Q3
$11M Buy
+213,782
New +$11.2M 0.05% 238
2018
Q4
Sell
-36,193
Closed -$1.48M 573
2018
Q3
$1.48M Sell
36,193
-2,980
-8% -$141K 0.01% 340
2018
Q2
$1.99M Sell
39,173
-5,307
-12% -$269K 0.01% 305
2018
Q1
$2.31M Sell
44,480
-21,820
-33% -$1.13M 0.01% 303
2017
Q4
$3.31M Buy
66,300
+28,600
+76% +$1.48M 0.02% 279
2017
Q3
$1.92M Buy
+37,700
New +$1.78M 0.01% 328

Other funds holding PCH

Grantham, Mayo, Van Otterloo & Co (GMO)'s PCH Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of PotlatchDeltic (PCH) in Q1 2026, closing a stake of 178,189 shares — an estimated $7.09M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PCH in Q3 2017 and held it in 22 quarters. The position peaked at $41.4M in Q1 2024. 2 funds tracked by Wall St. Rank hold PCH as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining PotlatchDeltic position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 178,189 PotlatchDeltic shares in Q1 2026, an estimated $7.09M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PotlatchDeltic in Q3 2017 and held it in 22 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s PotlatchDeltic position peaked at $41.4M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held PotlatchDeltic as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.